Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jim Turner

Showing results (21-30 of 33) with videos related to

Pageof 4
Sort By:
Injury|June 20, 2017
Do trauma courses change practice? A qualitative review of 20 courses in East, Central and Southern AfricaRele Ologunde, Grace Le, Jim Turner, et al.
Journal of Healthcare Information Management : JHIM|April 11, 2002
HIPAA Readiness Collaborative in HawaiiMarva Chun, Susan Forbes, Steven Gose, et al.
Familial Cancer|September 30, 2008
Patient preferences and National Health Service costs: a cost-consequences analysis of cancer genetic servicesGethin L Griffith, Rhiannon Tudor Edwards, J Mark G Williams, et al.
BMC Health Services Research|January 7, 2014
Patient-reported measurement of time to diagnosis in cancer: development of the Cancer Symptom Interval Measure (C-SIM) and randomised controlled trial of method of deliveryRichard D Neal, Sadia Nafees, Diana Pasterfield, et al.
Bioorganic & Medicinal Chemistry Letters|September 1, 2007
Thiophene substituted acylguanidines as BACE1 inhibitorsWilliam F Fobare, William R Solvibile, Albert J Robichaud, et al.
Journal of Medicinal Chemistry|September 18, 2009
Aminoimidazoles as potent and selective human beta-secretase (BACE1) inhibitorsMichael S Malamas, Jim Erdei, Iwan Gunawan, et al.
Bioorganic & Medicinal Chemistry Letters|October 1, 2010
Design and synthesis of aminohydantoins as potent and selective human β-secretase (BACE1) inhibitors with enhanced brain permeabilityMichael S Malamas, Albert Robichaud, Jim Erdei, et al.
Journal of Medicinal Chemistry|December 9, 2009
Design and synthesis of 5,5'-disubstituted aminohydantoins as potent and selective human beta-secretase (BACE1) inhibitorsMichael S Malamas, Jim Erdei, Iwan Gunawan, et al.
Bioorganic & Medicinal Chemistry|January 5, 2010
Di-substituted pyridinyl aminohydantoins as potent and highly selective human beta-secretase (BACE1) inhibitorsMichael S Malamas, Keith Barnes, Matthew Johnson, et al.
Bioorganic & Medicinal Chemistry Letters|August 13, 2011
New pyrazolyl and thienyl aminohydantoins as potent BACE1 inhibitors: exploring the S2' regionMichael S Malamas, Jim Erdei, Iwan Gunawan, et al.
Pageof 4

Showing results (21-30 of 33) with videos related to

Sort By:
Pageof 4
Injury|June 20, 2017
Do trauma courses change practice? A qualitative review of 20 courses in East, Central and Southern AfricaRele Ologunde, Grace Le, Jim Turner, et al.
Journal of Healthcare Information Management : JHIM|April 11, 2002
HIPAA Readiness Collaborative in HawaiiMarva Chun, Susan Forbes, Steven Gose, et al.
Familial Cancer|September 30, 2008
Patient preferences and National Health Service costs: a cost-consequences analysis of cancer genetic servicesGethin L Griffith, Rhiannon Tudor Edwards, J Mark G Williams, et al.
BMC Health Services Research|January 7, 2014
Patient-reported measurement of time to diagnosis in cancer: development of the Cancer Symptom Interval Measure (C-SIM) and randomised controlled trial of method of deliveryRichard D Neal, Sadia Nafees, Diana Pasterfield, et al.
Bioorganic & Medicinal Chemistry Letters|September 1, 2007
Thiophene substituted acylguanidines as BACE1 inhibitorsWilliam F Fobare, William R Solvibile, Albert J Robichaud, et al.
Journal of Medicinal Chemistry|September 18, 2009
Aminoimidazoles as potent and selective human beta-secretase (BACE1) inhibitorsMichael S Malamas, Jim Erdei, Iwan Gunawan, et al.
Bioorganic & Medicinal Chemistry Letters|October 1, 2010
Design and synthesis of aminohydantoins as potent and selective human β-secretase (BACE1) inhibitors with enhanced brain permeabilityMichael S Malamas, Albert Robichaud, Jim Erdei, et al.
Journal of Medicinal Chemistry|December 9, 2009
Design and synthesis of 5,5'-disubstituted aminohydantoins as potent and selective human beta-secretase (BACE1) inhibitorsMichael S Malamas, Jim Erdei, Iwan Gunawan, et al.
Bioorganic & Medicinal Chemistry|January 5, 2010
Di-substituted pyridinyl aminohydantoins as potent and highly selective human beta-secretase (BACE1) inhibitorsMichael S Malamas, Keith Barnes, Matthew Johnson, et al.
Bioorganic & Medicinal Chemistry Letters|August 13, 2011
New pyrazolyl and thienyl aminohydantoins as potent BACE1 inhibitors: exploring the S2' regionMichael S Malamas, Jim Erdei, Iwan Gunawan, et al.
Pageof 4